EMS World Expo
Our team will be on site in Orlando. If you work in prehospital care and want to see how AI ECG analysis can support field decisions and STEMI/OMI triage, get in touch and let's meet at the show.
Orlando, Florida, USA
September 28 – October 2, 2026
Now in its 38th year, EMS World Expo is the largest annual gathering of EMS professionals in the world. More than 7,000 attendees from over 50 countries — EMTs, paramedics, educators, medical directors, nurses and other prehospital clinicians — come together for five days of education, hands-on training and networking.
The programme offers 200+ sessions across nine learning tracks, two days of preconference workshops, an international scientific symposium, and a 100,000 sq ft exhibit hall with 300+ industry partners. It is co-located with the National Association of Emergency Medical Technicians (NAEMT) Annual Meeting, making it the key week for the North American prehospital community.
The exhibit hall and main conference run 30 September – 2 October.
- Venue: Orange County Convention Center, Orlando, Florida, USA
- Organiser: HMP Global / EMS World, co-located with the NAEMT Annual Meeting
- Website: hmpglobalevents.com
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.